PFBT
SANA icon

Parkside Financial Bank & Trust’s Sana Biotechnology SANA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536 Hold
186
– – ﹤0.01% 2557
2025
Q4 		$758 Hold
186
– – ﹤0.01% 2435
2025
Q3 		$661 Hold
186
– – ﹤0.01% 2433
2025
Q2 		$278 Buy
186
+41
+28% +$85 ﹤0.01% 2650
2025
Q1 		$244 Buy
+145
New +$405 ﹤0.01% 2655

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Parkside Financial Bank & Trust's SANA Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Sana Biotechnology (SANA) position steady in Q1 2026 at 186 shares worth $536. The position accounts for ﹤0.01% of the portfolio, ranked #2557.

Parkside Financial Bank & Trust first reported a position in SANA in Q1 2025 and has held it in 5 quarters since. The position peaked at $758 in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Parkside Financial Bank & Trust held 186 shares of Sana Biotechnology worth $536 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2557 holding.
  • Parkside Financial Bank & Trust first reported a position in Sana Biotechnology in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Sana Biotechnology position peaked at $758 in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.